Hansa Biopharma is an innovative and rapidly growing biopharmaceutical company that leverage its unique enzyme technology to develop innovative and potentially lifesaving and life altering immunomodulating therapies for rare autoimmune conditions, transplant rejection and cancer. 

Biotechnology

Hansa Biopharma

Søren Tulstrup

Gabriella Lindh von Koch

Gina Ewy

Emanuel Björne

Stephanie Kenney

Evan Ballantyne

Hitto Kaufmann

Poul Manniche

Suzanne Frank

Max Sakajja

Mark Wallace

Magnus Korsgren

Katja Gustafsson

Johan Oskarsson

Henk Doude van Troostwijk

Anne Säfström Lanner

Scientific Research Team

Clinical Research Team

Business Development & Market Access

Leadership Team

Finance and Accounting

Medical and Scientific Affairs

Human Resources Team

Information Technology and Operations

Teams at Hansa Biopharma